Gyon Technologies Capital Management, LP - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 178 filers reported holding PTC THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.00 and the average weighting 0.1%.

Quarter-by-quarter ownership
Gyon Technologies Capital Management, LP ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$594,000
-68.0%
14,906
-66.1%
0.11%
-81.9%
Q2 2021$1,859,000
+541.0%
43,971
+617.4%
0.61%
+383.3%
Q1 2021$290,000
-60.6%
6,129
-49.2%
0.13%
-50.2%
Q4 2020$736,000
+38.6%
12,057
+6.1%
0.25%
-39.3%
Q3 2020$531,000
-11.9%
11,364
-4.4%
0.42%
-71.4%
Q2 2020$603,000
-9.9%
11,892
-14.6%
1.46%
+229.6%
Q4 2019$669,00013,9250.44%
Other shareholders
PTC THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,750,000$84,053,0007.32%
RTW INVESTMENTS, LP 3,832,480$184,074,0006.94%
Burrage Capital Management LLC 195,725$9,401,0006.30%
Asymmetry Capital Management, L.P. 55,408$2,661,0004.77%
SECTORAL ASSET MANAGEMENT INC 328,738$15,789,0002.36%
ARMISTICE CAPITAL, LLC 758,000$36,407,0002.10%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 114,000$5,470,0001.97%
Opaleye Management Inc. 191,000$9,174,0001.80%
Sofinnova Investments, Inc. 517,092$24,836,0001.79%
Chubb Ltd 8,180$393,0001.68%
View complete list of PTC THERAPEUTICS INC shareholders